Stoke Therapeutics, Inc. (STOK) Financials

STOK Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 443.3 million 48.4 million
Dec. 31, 2025 418.4 million 66.0 million
Sept. 30, 2025 360.3 million 52.2 million
June 30, 2025 384.5 million 49.6 million

STOK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -60.9 million 8.8 million
Dec. 31, 2025 -30.7 million 9.8 million
Sept. 30, 2025 -30.5 million 8.0 million
June 30, 2025 -25.6 million 7.6 million

STOK Net Income

No data available :(

STOK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 343.5 million - 990000
Dec. 31, 2025 284.7 million - 3.0 million
Sept. 30, 2025 248.3 million - 2.9 million
June 30, 2025 247.7 million - 2.3 million

STOK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 63.1 million
Dec. 31, 2025 58.4 million
Sept. 30, 2025 58.6 million
June 30, 2025 58.4 million

STOK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 353000 39.7 million 20.0 million -
Dec. 31, 2025 232000 41.3 million 20.5 million -
Sept. 30, 2025 132000 37.3 million 15.5 million -
June 30, 2025 154000 25.9 million 15.3 million -

STOK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 6.2 million 1.0 million
Dec. 31, 2025 1.4 million 1.1 million
Sept. 30, 2025 10.6 million 989000
June 30, 2025 13.8 million 1.1 million

STOK

Price: $30

52 week price:
10.64
40.22

Earnings Per Share: -2.86 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 66686

Market Capitalization: 1.8 billion

Links: